Magnetic resonance spectroscopy (MRS) studies in alcohol use disorder (AUD) typically report lower levels of N-acetylaspartate (NAA) and choline-containing compounds (Cho) in several brain regions. Metabolite levels, however, are labile and can be affected by several competing factors, some related to drinking variables.. This in vivo MRS study included 20 recently sober (19.6 7 12.6 days) individuals with AUD and 15 controls. MRS was performed in single voxels placed in frontal white matter and thalamic regions using Constant-Time Point Resolved Spectroscopy (CT-PRESS) for absolute quantification of NAA, Cho, total creatine (tCr), and glutamate (Glu). A trend toward a thalamic NAA deficit in the total AUD group compared with controls was attributable to the subgroup of alcoholics who relapsed 3 or so months after scanning. In the total AUD group, frontal and thalamic NAA and Cho levels were lower with more recent drinking; frontal and thalamic Cho levels were also lower in AUD individuals with past stimulant abuse. Thalamic Cho levels were higher in binge-drinking AUD individuals and in those with longer length of alcohol dependence. MRS-visible metabolite peaks appear to be modulated by variables related to drinking behaviors, suggesting a sensitivity of MRS in tracking and predicting the dynamic course of alcoholism.
Introduction
Most magnetic resonance spectroscopy (MRS) studies report lower levels of N-acetylaspartate (NAA) in recently sober subjects with alcohol use disorders (AUD) relative to healthy controls in several brain regions including frontal areas (Bendszus et al., 2001; Durazzo et al., 2004 Durazzo et al., , 2010 Fein et al., 1994; Jagannathan et al., 1996; Schweinsburg et al., 2003) and cerebellum (Bendszus et al., 2001; Durazzo et al., 2010; Jagannathan et al., 1996; Parks et al., 2002; Seitz et al., 1999) . Levels of NAA, which when compromised can, in certain cases, reflect neuronal loss or damage (Moffett et al., 2007) , and are useful in determining regions of the brain that are particularly susceptible to the untoward effects of alcohol. Similarly, below control levels of choline-containing compounds (Cho) in AUD patients shortly following detoxification are also reported in frontal (Durazzo et al., 2004; Ende et al., 2005; Fein et al., 1994) and cerebellar (Bendszus et al., 2001; Ende et al., 2005; Parks et al., 2002; Seitz et al., 1999) regions (but see, Hermann et al., 2012; Modi et al., 2011) . Together with changes in NAA levels, changes in Cho levels can be used, theoretically, to distinguish neuronal from glial targets of brain pathology (Fein et al., 1994) . MRS studies suggest that both NAA (e.g., Bartsch et al., 2007; Bendszus et al., 2001; Parks et al., 2002) , particularly in frontal (Bartsch et al., 2007; Bendszus et al., 2001; Durazzo et al., 2006) and cerebellar (Bendszus et al., 2001; Fein et al., 1994; Parks et al., 2002) regions, and Cho (e.g., Bartsch et al., 2007; Bendszus et al., 2001; Durazzo et al., 2006; Ende et al., 2005; Martin et al., 1995) levels show normalization (i.e., increase) with abstinence. By contrast, elevated levels of Cho have been noted in non-abstinent chronic heavy drinkers (Meyerhoff et al., 2004) , social and moderate drinkers (Ende et al., 2006) , and rodents exposed to binge alcohol (e.g., Zahr et al., 2010 Zahr et al., , 2009 .
At least two-thirds of AUD individuals return to drinking within months of initiating recovery (e.g., Sinha, 2007) . Using in vivo MR imaging (MRI) results, the neural correlates of relapse risk have begun to be explored. The most substantial evidence thus far supports the integrity of frontal regions in the maintenance of sobriety (e.g., Sorg et al., 2012 
